Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 44 entries
Sorted by: Best Match Show Resources per page
Campylobacter fetus infection presenting with bacteremia and cellulitis in a 72-year-old man with an implanted pacemaker: a case report.

Journal of medical case reports

Ledina D, Ivić I, Karanović J, Karanović N, Kuzmičić N, Ledina D, Puljiz Z.
PMID: 23198848
J Med Case Rep. 2012 Nov 30;6:414. doi: 10.1186/1752-1947-6-414.

INTRODUCTION: Campylobacter is an important causative agent of intestinal infections in humans. Bacteremia is detected in less than 1% of patients, mainly in immunocompromised patients and in extreme age groups. Cellulitis is a relatively common manifestation of Campylobacter infection,...

Cite
Ledina D, Ivić I, Karanović J, et al. Campylobacter fetus infection presenting with bacteremia and cellulitis in a 72-year-old man with an implanted pacemaker: a case report. J Med Case Rep. 2012;6:414doi: 10.1186/1752-1947-6-414.
Ledina, D., Ivić, I., Karanović, J., Karanović, N., Kuzmičić, N., Ledina, D., & Puljiz, Z. (2012). Campylobacter fetus infection presenting with bacteremia and cellulitis in a 72-year-old man with an implanted pacemaker: a case report. Journal of medical case reports, 6414. https://doi.org/10.1186/1752-1947-6-414
Ledina, Dragan, et al. "Campylobacter fetus infection presenting with bacteremia and cellulitis in a 72-year-old man with an implanted pacemaker: a case report." Journal of medical case reports vol. 6 (2012): 414. doi: https://doi.org/10.1186/1752-1947-6-414
Ledina D, Ivić I, Karanović J, Karanović N, Kuzmičić N, Ledina D, Puljiz Z. Campylobacter fetus infection presenting with bacteremia and cellulitis in a 72-year-old man with an implanted pacemaker: a case report. J Med Case Rep. 2012 Nov 30;6:414. doi: 10.1186/1752-1947-6-414. PMID: 23198848; PMCID: PMC3520688.
Copy Download .nbib Format: NLM
Treatment of 112 bone and joint infections with teicoplanin.

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie

Dacquet V, Biron F, Gontier D, Choquet-Kasylevsky G, Niwiczka A, Harding I, Atlani C, Peyramond D.
PMID: 24193675
Eur J Orthop Surg Traumatol. 1996 May;6(2):109-13. doi: 10.1007/BF00568325.

Teicoplanin was used in three hospitals over 6 years in 112 cases of bone or joint infection and the results were reviewed retrospectively. Teicoplanin was used at a dose of 400 mg/day, after a 3-day loading regimen, in combination...

Cite
Dacquet V, Biron F, Gontier D, et al. Traitement de 122 infections ostéo-articulaires avec la Teicoplanine. Treatment of 112 bone and joint infections with teicoplanin. Eur J Orthop Surg Traumatol. 1996;6(2):109-13doi: 10.1007/BF00568325.
Dacquet, V., Biron, F., Gontier, D., Choquet-Kasylevsky, G., Niwiczka, A., Harding, I., Atlani, C., & Peyramond, D. (1996). Traitement de 122 infections ostéo-articulaires avec la Teicoplanine. Treatment of 112 bone and joint infections with teicoplanin. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 6(2), 109-13. https://doi.org/10.1007/BF00568325
Dacquet, V, et al. "Traitement de 122 infections ostéo-articulaires avec la Teicoplanine." Treatment of 112 bone and joint infections with teicoplanin. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie vol. 6,2 (1996): 109-13. doi: https://doi.org/10.1007/BF00568325
Dacquet V, Biron F, Gontier D, Choquet-Kasylevsky G, Niwiczka A, Harding I, Atlani C, Peyramond D. Traitement de 122 infections ostéo-articulaires avec la Teicoplanine. Treatment of 112 bone and joint infections with teicoplanin. Eur J Orthop Surg Traumatol. 1996 May;6(2):109-13. doi: 10.1007/BF00568325. PMID: 24193675.
Copy Download .nbib Format: NLM
Bacteriological profile of neonatal septicemia and antibiotic susceptibility pattern of the isolates.

Journal of natural science, biology, and medicine

Jyothi P, Basavaraj MC, Basavaraj PV.
PMID: 24082722
J Nat Sci Biol Med. 2013 Jul;4(2):306-9. doi: 10.4103/0976-9668.116981.

CONTEXT: Septicemia in neonates refers to generalized bacterial infection documented by positive blood culture in the first four weeks of life and is one of the four leading causes of neonatal mortality and morbidity in India.AIM: To isolate and...

Cite
Jyothi P, Basavaraj MC, Basavaraj PV. Bacteriological profile of neonatal septicemia and antibiotic susceptibility pattern of the isolates. J Nat Sci Biol Med. 2013;4(2):306-9doi: 10.4103/0976-9668.116981.
Jyothi, P., Basavaraj, M. C., & Basavaraj, P. V. (2013). Bacteriological profile of neonatal septicemia and antibiotic susceptibility pattern of the isolates. Journal of natural science, biology, and medicine, 4(2), 306-9. https://doi.org/10.4103/0976-9668.116981
Jyothi, P, et al. "Bacteriological profile of neonatal septicemia and antibiotic susceptibility pattern of the isolates." Journal of natural science, biology, and medicine vol. 4,2 (2013): 306-9. doi: https://doi.org/10.4103/0976-9668.116981
Jyothi P, Basavaraj MC, Basavaraj PV. Bacteriological profile of neonatal septicemia and antibiotic susceptibility pattern of the isolates. J Nat Sci Biol Med. 2013 Jul;4(2):306-9. doi: 10.4103/0976-9668.116981. PMID: 24082722; PMCID: PMC3783770.
Copy Download .nbib Format: NLM
A new eye gel containing sodium hyaluronate and xanthan gum for the management of post-traumatic corneal abrasions.

Clinical ophthalmology (Auckland, N.Z.)

Faraldi F, Papa V, Santoro D, Rasà D, Mazza AL, Rabbione MM, Russo S.
PMID: 22654499
Clin Ophthalmol. 2012;6:727-31. doi: 10.2147/OPTH.S31776. Epub 2012 May 09.

PURPOSE: The aim of this study was to investigate the effects of an ophthalmic gel containing sodium hyaluronate and xanthan gum in addition to the antibiotic netilmicin in the management of traumatic corneal abrasions.PATIENTS AND METHODS: PATIENTS WITH TRAUMATIC...

Cite
Faraldi F, Papa V, Santoro D, et al. A new eye gel containing sodium hyaluronate and xanthan gum for the management of post-traumatic corneal abrasions. Clin Ophthalmol. 2012;6:727-31doi: 10.2147/OPTH.S31776.
Faraldi, F., Papa, V., Santoro, D., Rasà, D., Mazza, A. L., Rabbione, M. M., & Russo, S. (2012). A new eye gel containing sodium hyaluronate and xanthan gum for the management of post-traumatic corneal abrasions. Clinical ophthalmology (Auckland, N.Z.), 6727-31. https://doi.org/10.2147/OPTH.S31776
Faraldi, Francesco, et al. "A new eye gel containing sodium hyaluronate and xanthan gum for the management of post-traumatic corneal abrasions." Clinical ophthalmology (Auckland, N.Z.) vol. 6 (2012): 727-31. doi: https://doi.org/10.2147/OPTH.S31776
Faraldi F, Papa V, Santoro D, Rasà D, Mazza AL, Rabbione MM, Russo S. A new eye gel containing sodium hyaluronate and xanthan gum for the management of post-traumatic corneal abrasions. Clin Ophthalmol. 2012;6:727-31. doi: 10.2147/OPTH.S31776. Epub 2012 May 09. PMID: 22654499; PMCID: PMC3363309.
Copy Download .nbib Format: NLM
Comparative effects of gentamicin and netilmicin on Na(+)-dependent d-glucose transport in rabbit renal brush-border membrane vesicles.

Toxicology in vitro : an international journal published in association with BIBRA

Moriyama T, Nakahama H, Fukuhara Y, Ueda N, Orita Y, Kamada T.
PMID: 20732018
Toxicol In Vitro. 1991;5(3):211-8. doi: 10.1016/0887-2333(91)90020-e.

The effects of gentamicin and netilmicin administration on Na(+)-dependent d-glucose transport in rabbit renal brush-border membrane vesicles (BBMV) were investigated. BBMV were isolated from rabbit kidney outer cortex (early proximal tubule) and outer medulla (late proximal tubule) 60 min...

Cite
Moriyama T, Nakahama H, Fukuhara Y, et al. Comparative effects of gentamicin and netilmicin on Na(+)-dependent d-glucose transport in rabbit renal brush-border membrane vesicles. Toxicol In Vitro. 1991;5(3):211-8doi: 10.1016/0887-2333(91)90020-e.
Moriyama, T., Nakahama, H., Fukuhara, Y., Ueda, N., Orita, Y., & Kamada, T. (1991). Comparative effects of gentamicin and netilmicin on Na(+)-dependent d-glucose transport in rabbit renal brush-border membrane vesicles. Toxicology in vitro : an international journal published in association with BIBRA, 5(3), 211-8. https://doi.org/10.1016/0887-2333(91)90020-e
Moriyama, T, et al. "Comparative effects of gentamicin and netilmicin on Na(+)-dependent d-glucose transport in rabbit renal brush-border membrane vesicles." Toxicology in vitro : an international journal published in association with BIBRA vol. 5,3 (1991): 211-8. doi: https://doi.org/10.1016/0887-2333(91)90020-e
Moriyama T, Nakahama H, Fukuhara Y, Ueda N, Orita Y, Kamada T. Comparative effects of gentamicin and netilmicin on Na(+)-dependent d-glucose transport in rabbit renal brush-border membrane vesicles. Toxicol In Vitro. 1991;5(3):211-8. doi: 10.1016/0887-2333(91)90020-e. PMID: 20732018.
Copy Download .nbib Format: NLM
The clinical and bacteriogical spectrum of neonatal sepsis in a tertiary hospital in yaounde, cameroon.

Iranian journal of pediatrics

Chiabi A, Djoupomb M, Mah E, Nguefack S, Mbuagbaw L, Zafack J, Ghoyap M, Nkoa T, Tchokoteu PF.
PMID: 23056829
Iran J Pediatr. 2011 Dec;21(4):441-8.

OBJECTIVE: Sepsis is an important cause of morbidity and mortality in neonates especially in developing countries where identification of the germs and treatment is often unsatisfactory. The aim of the study was to assess the clinical presentation, and bacteriological...

Cite
Chiabi A, Djoupomb M, Mah E, et al. The clinical and bacteriogical spectrum of neonatal sepsis in a tertiary hospital in yaounde, cameroon. Iran J Pediatr. 2011;21(4):441-8
Chiabi, A., Djoupomb, M., Mah, E., Nguefack, S., Mbuagbaw, L., Zafack, J., Ghoyap, M., Nkoa, T., & Tchokoteu, P. F. (2011). The clinical and bacteriogical spectrum of neonatal sepsis in a tertiary hospital in yaounde, cameroon. Iranian journal of pediatrics, 21(4), 441-8.
Chiabi, Andreas, et al. "The clinical and bacteriogical spectrum of neonatal sepsis in a tertiary hospital in yaounde, cameroon." Iranian journal of pediatrics vol. 21,4 (2011): 441-8.
Chiabi A, Djoupomb M, Mah E, Nguefack S, Mbuagbaw L, Zafack J, Ghoyap M, Nkoa T, Tchokoteu PF. The clinical and bacteriogical spectrum of neonatal sepsis in a tertiary hospital in yaounde, cameroon. Iran J Pediatr. 2011 Dec;21(4):441-8. PMID: 23056829; PMCID: PMC3446127.
Copy Download .nbib Format: NLM
Netilmicin-induced carpopedal spasm.

Journal of pharmacology & pharmacotherapeutics

Ramani RY, Panigrahy B, Rath B.
PMID: 25210404
J Pharmacol Pharmacother. 2014 Jul;5(3):211-3. doi: 10.4103/0976-500X.136112.

Aminoglycoside-induced nephrotoxicity is not uncommon. Netilmicin being a member of gentamicin family has the advantage of being relatively free from ototoxicity and nephrotoxicity and is also prescribed for gentamicin resistant cases. In spite of these benefits with netilmicin, occasional...

Cite
Ramani RY, Panigrahy B, Rath B. Netilmicin-induced carpopedal spasm. J Pharmacol Pharmacother. 2014;5(3):211-3doi: 10.4103/0976-500X.136112.
Ramani, R. Y., Panigrahy, B., & Rath, B. (2014). Netilmicin-induced carpopedal spasm. Journal of pharmacology & pharmacotherapeutics, 5(3), 211-3. https://doi.org/10.4103/0976-500X.136112
Ramani, Roja Y, et al. "Netilmicin-induced carpopedal spasm." Journal of pharmacology & pharmacotherapeutics vol. 5,3 (2014): 211-3. doi: https://doi.org/10.4103/0976-500X.136112
Ramani RY, Panigrahy B, Rath B. Netilmicin-induced carpopedal spasm. J Pharmacol Pharmacother. 2014 Jul;5(3):211-3. doi: 10.4103/0976-500X.136112. PMID: 25210404; PMCID: PMC4156835.
Copy Download .nbib Format: NLM
Synthesis, ribosomal selectivity, and antibacterial activity of netilmicin 4'-derivatives.

MedChemComm

Sonousi A, Shcherbakov D, Vasella A, Böttger EC, Crich D.
PMID: 31303992
Medchemcomm. 2019 Apr 25;10(6):946-950. doi: 10.1039/c9md00153k. eCollection 2019 Jun 01.

Halogenation of a suitably protected netilmicin derivative enables preparation of 4'-chloro-, bromo-, and iodo derivatives of netilmicin after deprotection. Suzuki coupling of a protected 4'-bromo derivative with phenylboronic acid or butyltrifluoroborate affords the corresponding 4'-phenyl and 4'-butyl derivatives of...

Cite
Sonousi A, Shcherbakov D, Vasella A, et al. Synthesis, ribosomal selectivity, and antibacterial activity of netilmicin 4'-derivatives. Medchemcomm. 2019;10(6):946-950doi: 10.1039/c9md00153k.
Sonousi, A., Shcherbakov, D., Vasella, A., Böttger, E. C., & Crich, D. (2019). Synthesis, ribosomal selectivity, and antibacterial activity of netilmicin 4'-derivatives. MedChemComm, 10(6), 946-950. https://doi.org/10.1039/c9md00153k
Sonousi, Amr, et al. "Synthesis, ribosomal selectivity, and antibacterial activity of netilmicin 4'-derivatives." MedChemComm vol. 10,6 (2019): 946-950. doi: https://doi.org/10.1039/c9md00153k
Sonousi A, Shcherbakov D, Vasella A, Böttger EC, Crich D. Synthesis, ribosomal selectivity, and antibacterial activity of netilmicin 4'-derivatives. Medchemcomm. 2019 Apr 25;10(6):946-950. doi: 10.1039/c9md00153k. eCollection 2019 Jun 01. PMID: 31303992; PMCID: PMC6595968.
Copy Download .nbib Format: NLM
Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Kondo S, Hotta K.
PMID: 11810483
J Infect Chemother. 1999 Mar;5(1):1-9. doi: 10.1007/s101560050001.

The critical resistance mechanisms of aminoglycoside antibiotics in bacteria of clinical importance are the enzymatic N-acetylation, O-phosphorylation, and O-nucleotidylation that generally result in the inactivation of aminoglycosides. To overcome such resistance mechanisms, dibekacin (3',4'-dideoxykanamycin B) was developed as the...

Cite
Kondo S, Hotta K. Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications. J Infect Chemother. 1999;5(1):1-9doi: 10.1007/s101560050001.
Kondo, S., & Hotta, K. (1999). Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 5(1), 1-9. https://doi.org/10.1007/s101560050001
Kondo, S., and Hotta, Kunimoto. "Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications." Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy vol. 5,1 (1999): 1-9. doi: https://doi.org/10.1007/s101560050001
Kondo S, Hotta K. Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications. J Infect Chemother. 1999 Mar;5(1):1-9. doi: 10.1007/s101560050001. PMID: 11810483.
Copy Download .nbib Format: NLM
Can Aminoglycosides Be Used as a New Treatment for .

Infection & chemotherapy

Lee KH, Park SY, Jeong SJ, Jung DH, Kim JH, Jeong SH, Kang IM, Song YG.
PMID: 30941933
Infect Chemother. 2019 Mar;51(1):10-20. doi: 10.3947/ic.2019.51.1.10.

BACKGROUND: Smectite can serve as a drug delivery system and gentamicin-intercalated smectite hybrids are expected to supersede the standard therapy for MATERIALS AND METHODS: A total of 140 strains were collected for a minimum period of 3 years. Antimicrobial...

Cite
Lee KH, Park SY, Jeong SJ, et al. Can Aminoglycosides Be Used as a New Treatment for . Infect Chemother. 2019;51(1):10-20doi: 10.3947/ic.2019.51.1.10.
Lee, K. H., Park, S. Y., Jeong, S. J., Jung, D. H., Kim, J. H., Jeong, S. H., Kang, I. M., & Song, Y. G. (2019). Can Aminoglycosides Be Used as a New Treatment for . Infection & chemotherapy, 51(1), 10-20. https://doi.org/10.3947/ic.2019.51.1.10
Lee, Kyoung Hwa, et al. "Can Aminoglycosides Be Used as a New Treatment for ." Infection & chemotherapy vol. 51,1 (2019): 10-20. doi: https://doi.org/10.3947/ic.2019.51.1.10
Lee KH, Park SY, Jeong SJ, Jung DH, Kim JH, Jeong SH, Kang IM, Song YG. Can Aminoglycosides Be Used as a New Treatment for . Infect Chemother. 2019 Mar;51(1):10-20. doi: 10.3947/ic.2019.51.1.10. PMID: 30941933; PMCID: PMC6446016.
Copy Download .nbib Format: NLM
Detection of Multidrug Resistant (MDR) and Extremely Drug Resistant (XDR) P. Aeruginosa Isolated from Patients in Tehran, Iran.

Iranian journal of pathology

Saderi H, Owlia P.
PMID: 26351496
Iran J Pathol. 2015;10(4):265-71.

BACKGROUND: This study was done to detect multidrug resistant (MDR) and extremely drug resistant (XDR) of Pseudomonas aeruginosa among strains isolated from patients in Tehran, Iran, due to importance of these phenotypes in treatment of human infections.METHODS: Eighty eight...

Cite
Saderi H, Owlia P. Detection of Multidrug Resistant (MDR) and Extremely Drug Resistant (XDR) P. Aeruginosa Isolated from Patients in Tehran, Iran. Iran J Pathol. 2015;10(4):265-71
Saderi, H., & Owlia, P. (2015). Detection of Multidrug Resistant (MDR) and Extremely Drug Resistant (XDR) P. Aeruginosa Isolated from Patients in Tehran, Iran. Iranian journal of pathology, 10(4), 265-71.
Saderi, Horieh, and Owlia, Parviz. "Detection of Multidrug Resistant (MDR) and Extremely Drug Resistant (XDR) P. Aeruginosa Isolated from Patients in Tehran, Iran." Iranian journal of pathology vol. 10,4 (2015): 265-71.
Saderi H, Owlia P. Detection of Multidrug Resistant (MDR) and Extremely Drug Resistant (XDR) P. Aeruginosa Isolated from Patients in Tehran, Iran. Iran J Pathol. 2015;10(4):265-71. PMID: 26351496; PMCID: PMC4539747.
Copy Download .nbib Format: NLM
Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up.

Experimental and therapeutic medicine

Magri V, Montanari E, Marras E, Perletti G.
PMID: 27698761
Exp Ther Med. 2016 Oct;12(4):2585-2593. doi: 10.3892/etm.2016.3631. Epub 2016 Aug 30.

Although fluoroquinolones are first-line agents for the treatment of National Institutes of Health (NIH) category II chronic bacterial prostatitis (CBP), therapy with these agents is not always feasible due to the increasing worldwide resistance of causative uropathogens. New therapeutic...

Cite
Magri V, Montanari E, Marras E, et al. Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up. Exp Ther Med. 2016;12(4):2585-2593doi: 10.3892/etm.2016.3631.
Magri, V., Montanari, E., Marras, E., & Perletti, G. (2016). Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up. Experimental and therapeutic medicine, 12(4), 2585-2593. https://doi.org/10.3892/etm.2016.3631
Magri, Vittorio, et al. "Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up." Experimental and therapeutic medicine vol. 12,4 (2016): 2585-2593. doi: https://doi.org/10.3892/etm.2016.3631
Magri V, Montanari E, Marras E, Perletti G. Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up. Exp Ther Med. 2016 Oct;12(4):2585-2593. doi: 10.3892/etm.2016.3631. Epub 2016 Aug 30. PMID: 27698761; PMCID: PMC5038489.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 44 entries